Metastatic lung cancer is one of the most lethal forms of cancer and molecular pathways driving metastasis are still not clearly elucidated. Metastatic cancer cells undergo an epithelialmesenchymal transition (EMT) where they lose their epithelial properties and acquire a migratory and invasive phenotype. Here we identify that expression of microRNAs from the miR-200 family and the miR-183~96~182 cluster are significantly co-repressed in non-small cell lung cancer (NSCLC) cell lines and primary tumors from multiple TCGA data sets with high EMT scores. Ectopic expression of the miR-183~96~182 cluster inhibited cancer cell migration and invasion, while its expression was tightly modulated by miR-200. We identified Foxf2 as a common, novel and direct target of both these microRNA families. Foxf2 expression tightly correlates with the transcription factor Zeb1 and is elevated in mesenchymal-like metastatic lung cancer cells. Foxf2 expression induced robust EMT, migration, invasion and metastasis in lung cancer cells, whereas Foxf2 inhibition significantly repressed these phenotypes. We also demonstrated that Foxf2 transcriptionally represses E-Cadherin and miR-200, independent of Zeb1, to form a double negative feedback loop. We therefore identified a novel mechanism whereby the miR-200 family and the miR-183~96~182 cluster inhibit lung cancer invasion and metastasis by targeting Foxf2.
Introduction
Lung cancer is the leading cause of cancer related deaths in the world, primarily because of aggressive metastatic progression 60 . The high mortality for this disease derives partly from limited therapeutic interventions and necessitates an understanding of the molecular pathways driving metastasis. One of the mechanisms contributing to metastasis in epithelial tumors is epithelial-mesenchymal transition (EMT). During this process a subset of cells from the primary tumor acquires invasive and migratory properties with loss of epithelial cell polarity and intercellular adhesion 29 , 76 . A series of transcription factors/repressors regulate EMT by inhibiting epithelial genes like E-Cadherin and miR-200 and inducing mesenchymal markers like vimentin. The Zeb, Snail and Twist families of transcriptional repressors are the most well documented EMT regulators in different cancers 69 , 71 , 72 . To elucidate the molecular mechanisms underlying EMT and metastasis our laboratory has developed a syngeneic tumor model using cell lines isolated from a genetically-engineered murine model with mutant KRas and p53 77 . Syngeneic tumors in this model vary in their metastatic potential. MicroRNA expression profiling revealed that the microRNA-200 family (miR-200) is repressed in the highly metastatic tumors and exogenous expression of miR-200 in the metastatic cells resulted in their inability to undergo EMT and metastasize 2 , 23 , 73 .
MicroRNAs are 22 nucleotide non-coding RNAs that inhibit target genes by degrading the message or inhibiting translation 4 , 5 , 16 , 19 , 59 . Work from our lab and others has demonstrated that in many tumor types the microRNA-200 family (miR-200) modulates EMT by regulating the Zeb family of transcriptional repressors through a double-negative feedback loop 9 , 11 , 23 , 24 . Recently the miR-183~96~182 cluster was shown to be repressed by Zeb, in p21 deficient colon cancer cells undergoing EMT and were significantly more invasive and migratory 41 . miR-183 has been shown to inhibit cancer cell migration and metastasis in breast 44 and bone 75 cancer cells whereas it induced proliferative and migratory properties in soft tissue sarcomas 57 and medulloblastoma 68 . However a role for the miR-183~96~182 cluster in lung cancer is not defined.
Forkhead-box (Fox) is a super family of transcriptional regulators that have myriad functions from development and proliferation to oncogenesis. Fox proteins have a conserved wingedhelix DNA binding domain and less conserved non-Fox domains, which mediate interactions with other transcriptional regulators for specific functions 33 , 38 . The Foxf subfamily consists of two members, of which Foxf1 has been documented to induce EMT and invasion in breast cancers 47 . Foxf2 is required for gut development and promote extracellular matrix production 49 but little has been demonstrated on its role in cancer progression or metastasis. Here we provide evidence that the expression of miR-183~96~182 cluster is strongly correlated to miR-200 and EMT in NSCLC and multiple other epithelial tumor types. Both these microRNA families convergently target Foxf2, which can potently regulate EMT, invasion and metastasis in lung cancers by transcriptional repression of E-Cadherin and miR-200.
Results

Expression of miR-183~96~182 cluster is correlated with miR-200 and inhibits cell invasion
We generated microRNA expression profiles for 55 human NSCLC cell lines and applied a 76 gene EMT signature that we recently described to stratify them into epithelial-like and mesenchymal-like groups based on their gene expression pattern 12 , 14 . In addition to the miR-200 family members, the miR-183~96~182 cluster was significantly repressed in the mesenchymal-like cells lines (Fig. 1A) . Like miR-200, the members of the miR-183~96~182 cluster also demonstrated significant negative correlation with the EMT scores 12 of samples from multiple TCGA datasets (Fig. 1B and Supplementary. Fig. 1A-B) representing a range of epithelial tumors, thus indicating that both miR-200 and miR-183~96~182 cluster are strongly associated with an epithelial state in different tumor types. Additionally the miR-183~96~182 cluster displayed significant positive correlation with miR-200 for all the tumor datasets ( Supplementary Fig. 1C ). The expression of the miR-183~96~182 cluster was validated by quantitative RT-PCR in both a panel of human NSCLC cell lines with varying miR-200 levels ( Fig. 1C and Supplementary Fig. 1D ) and a panel of murine KP lung cancer lines where the miR-183~96~182 cluster expression was significantly lower in the metastatic mesenchymal cell lines (344SQ, 344LN, 531LN1, 531LN2) with low miR-200 expression (as described previously 2 , 23 ) than the epithelial nonmetastatic cell lines (393LN, 412P, 307P and 393P) with low Zeb1 and high miR-200 2 ( Fig.  1D ). Exogenous Zeb1 expression in epithelial human HCC827 ( Supplementary Fig. 1E -H) or murine 393P cell lines resulted in a significant repression of both the miR-200 family 2 , 23 ( Supplementary Fig. 1H ) and the miR-183~96~182 cluster ( Fig. 1E-F) . Conversely, inducible expression of miR-200a and/or -b in mesenchymal human H157 cells 14 significantly induced miR-183~96~182 cluster expression (Fig. 1G) . To test the functional role of miR-183~96~182 cluster on migration and invasion of NSCLC cells, human or mouse miR-96, 182 and 183 were transfected into mesenchymal human H157 (Fig. 1H ) or murine 344SQ cells (Fig. 1J ) respectively, which significantly suppressed both migration and invasion ( Fig. 1I-K) . These results suggest that like miR-200 the expression of the miR-183~96~182 cluster is strongly associated with the epithelial state of cancer cells and directly regulates cancer cell migration and invasion.
Foxf2 is a novel and direct target of miR-96/182 and miR-200b/c with strong correlation to Zeb1 expression
To investigate the mechanisms by which the mir-200 and the miR-183~96~182 cluster regulate EMT and subsequent cellular migration, invasion and metastasis in NSCLC, we searched for common predicted targets of these microRNA families. First we performed a cross comparison of multiple gene expression datasets from our mouse models of metastasis 23 . We overlapped 224 genes that were elevated greater than four-fold upon Zeb1 induction in 393P cells, with 210 genes that showed greater than two-fold increase in expression in the metastatic 344SQ cells compared to the non-metastatic 393P cells 23 and genes), using the microRNA prediction algorithm miRanda (www.microRNA.org) and identified a list of 17 highly conserved common targets (Supplementary Table 2 ) with a mirSVR 7 score less than −6.0 ( Fig. 2A) . The only 2 genes common in both the overlapping subsets were Zeb1 (ZFHX1A) and Foxf2. We also performed a gene set enrichment analysis on the mRNA profiles from our murine metastatic 344SQ and non-metastatic 393P tumors 23 and Foxf2 was again identified in the list of most differentially expressed genes in the metastatic mesenchymal 344SQ tumors (Supplementary Fig. 2A ). 
Foxf2 induces EMT, invasion and metastasis
To examine the biological role of Foxf2 in lung cancer, GFP-tagged Foxf2 was exogenously expressed under a doxycycline-inducible promoter in the non-metastatic murine epithelial 393P cells. Foxf2 expression in 393P cells induced a dramatic cellular phenotypic change from a cobble-stone, clustered, epithelial state to a fibroblastic, spindle-shaped, scattered mesenchymal morphology, which reverted upon doxycycline withdrawal (Fig. 3A) . Control GFP-expressing cells showed no morphologic change ( Supplementary Fig. 3A ). This morphologic shift upon 10 days of Foxf2 expression was concordant with a significant induction of Zeb1 and dramatic E-Cadherin repression both at the mRNA ( 3I ) but when grown in 3D matrigel/collagen I cultures, were more invasive compared to the GFP control cells ( Supplementary Fig. 3K ). These results demonstrate that Foxf2 induces EMT, cellular migration and invasion in cells that are normally epithelial and non-invasive.
To understand the potential role of Foxf2 during invasion and metastasis we wanted to determine whether Foxf2 could modulate these biologic functions in cells that are mesenchymal and have metastatic ability at baseline. For this Foxf2 was inducibly expressed in the murine 344SQ cell line. As in the 393P and 531P1 cells, induction resulted in robust Foxf2 expression, nuclear localization of the protein and an EMT-like change in the cellular morphology when compared to the GFP-expressing cells ( 4C ). Growth in 3D cultures revealed normal spheroid formation of the control 344SQ-GFP cells and remarkable invasive growth by the 344SQ-Foxf2 cells (Fig. 3H ). To determine their in vivo metastatic potencies, 344SQ-Foxf2 or control 344SQ-GFP induced cells were subcutaneously implanted into syngeneic mice. The primary tumor sizes for both the control and the Foxf2 expressing cells were comparable, consistent with no significant difference in cellular proliferation between the tumor types as evident from Ki67 staining ( Supplementary  Fig. 4D ). However, the mice with 344SQ-Foxf2 tumors demonstrated a ~3-fold increase in the number of metastatic lung nodules compared to the control cells ( Fig. 3I ) within just 4 weeks. This was confirmed by haematoxylin and eosin staining of lung sections from the groups (Fig. 3J) . These results establish Foxf2 as a potent suppressor of the epithelial phenotype, which arrests cells in a hyper-invasive state, producing rapid in vivo metastasis.
Foxf2 knockdown suppresses invasion and metastasis
To study the converse effect, we stably knocked down Foxf2 expression in mesenchymal mouse and human cells by shRNA vectors. Foxf2 knockdown in mouse mesenchymal and metastatic 344SQ cells (344SQ-Foxf2-shE) did not result in an apparent change in cell morphology (data not shown), cell proliferation ( Supplementary Fig. 4C ) or expression of the EMT markers ( Fig. 4A-B ), but significantly suppressed cellular migration and invasion in Boyden chambers ( Fig. 4C and Supplementary Fig. 3L ). Similarly in human H157 cells, knockdown of FOXF2 (H157-FOXF2-sh5) did not alter the expression of EMT genes ( Fig.  4D -E) but produced significant inhibition of migration and invasion compared to vector controls ( Fig. 4F and Supplementary Fig. 3M ). To test whether down-regulation of Foxf2 expression could alter the in vivo metastatic potencies, the 344SQ-Foxf2-shE (knockdown) and the 344SQ-pGIPZ-NS (control) cells were injected subcutaneously in syngeneic mice. Both groups formed comparable sized tumors at 8 weeks, with only a slight increase in proliferating cells in the primary tumors formed by the knockdown cells compared to the controls when assayed by Ki-67 staining ( Fig. 4G and Supplementary Fig. 4D ). In contrast, the Foxf2 knockdown cells exhibited significant repression of lung metastasis (Fig. 4G) , which was confirmed by haematoxylin and eosin stained lung sections (Fig. 4H) . These results confirm that inhibition of Foxf2 expression could significantly reduce the migratory and invasive capabilities of metastatic cells, abrogating in vivo metastasis. Interestingly by manipulating the levels of Foxf2 in the same (344SQ) cell line we could control the metastatic phenotype of the cells, highlighting the importance of Foxf2 as a metastasis regulator.
Foxf2 induces rapid repression of E-cadherin and miR-200 independent of Zeb1
Foxf2 expression induces a strong EMT-like phenotype with increased migration, invasion and metastasis, which is associated with a robust inhibition of E-Cadherin and up-regulation of Zeb1. To understand whether these two changes are a direct and acute consequence of Foxf2 expression, we performed a time course assay to determine the changes in expression of these two markers upon induction of Foxf2 in 393P cells. Upon Foxf2 induction, ECadherin was transcriptionally repressed as early as 4 hours (50% at RNA level) and reached its maximum by 48 hours (more than 95% by mRNA and protein level (60%)), whereas Zeb1 protein levels were not considerably elevated (14%) until 48 hours (Fig. 5A-B) . Induction of GFP (control vector) did not induce any marker changes ( Supplementary Fig.  5A -B). Since the miR-200 family is important regulator of the epithelial phenotype in lung cancer 23 , we examined whether they are regulated by Foxf2. We observed that mature miR-200a and miR-200b, but not miR-200c, were significantly repressed (70%) within 48 hours of Foxf2 induction (Fig. 5C ), whereas no significant changes were observed in the GFP vector cells (Supplementary Fig. 5C ). This was confirmed by similar repression of the miR-429 levels (70%) within 72 hours of Foxf2 induction, whereas miR-141 levels were unaltered ( Supplementary Fig. 5D ). These results suggest that Foxf2 might transcriptionally target only the miR-200b~200a~429 locus and not the miR-141~200c locus.
As the miR-200b~200a~429 cluster and E-cadherin are both known Zeb1 targets 9 , 17 , 22 , we sought to determine whether Foxf2-mediated repression of these two loci is dependent on Zeb1. Control siRNA or siRNA targeting Zeb1 were transfected into control 393P-GFP or 393P-Foxf2 cells and both mRNA and protein were isolated at time points after Foxf2 or GFP induction. Both in the presence and absence of Zeb1, E-Cadherin was significantly repressed upon 48 hours of Foxf2 induction, at the mRNA (>50%) (Fig. 5D ) and protein (40%) (Fig. 5E ) levels. No change was observed in the 393-GFP vector cells ( Supplementary Fig. 5E ). To confirm these findings, we generated stable 393P cells with inducible Foxf2 and either scramble (control) hairpin (393P-Foxf2-sh-scramble) or shRNA hairpin targeting Zeb1 (393P-Foxf2-shZeb1), which showed greater than 90% Zeb1 knockdown. Upon Foxf2 induction for 48 hours, E-Cadherin expression was significantly repressed both at RNA (50%) and protein (70%) levels in cells with endogenous Zeb1 expression. Similarly, in cells with stable knockdown of Zeb1, E-Cadherin was significantly repressed both at RNA (50%) and protein (65%) levels after 48 hours of Foxf2 induction ( Supplementary Fig. 5G-H) . Induction of GFP did not change the levels of E-Cadherin irrespective of Zeb1 status in the control cells (Supplementary Fig. 5F ). Similarly, quantitative PCR analysis for mature forms of mir-200a, -b or -c from 393P-Foxf2 (inducible) cells transfected with si-Control or si-Zeb1 revealed that they were significantly repressed upon Foxf2 induction, independent of Zeb1 status (Fig. 5F ).
To determine whether E-Cadherin and miR-200 repression are a result of direct inhibition of their promoter activities by Foxf2, we performed luciferase reporter assays using promoter constructs for E-Cadherin and the miR-200b~200a~429 cluster 9 . We observed a significant repression of activity from both the promoters upon Foxf2 induction (Fig. 5G) , which was independent of Zeb1, as demonstrated by use of siRNA targeting Zeb1 versus control siRNA in 393P-GFP (control) or 393P-Foxf2 inducible cells (Fig. 5H ). To further assess direct binding of Foxf2 to the endogenous promoters of E-Cadherin and miR-200b~200a~429, we performed ChIP assays with the 393P-GFP (control) or 393P-Foxf2 inducible cells. We observed specific binding and enrichment for Foxf2 at different segments of the E-Cadherin promoter (as indicated) and an unique segment ~2500 bp upstream from the start site of the miR-200b precursor (Fig. 5I ). All these enriched segments contain putative Foxf2 binding sites. Taken together these results demonstrate that Foxf2 transcriptionally represses ECadherin and miR-200b~200a~429 microRNA cluster, independent of Zeb1, to repress the epithelial phenotype and induce EMT, invasion and metastasis.
Based on our work here and the data in the literature, we propose a model in which the Zeb1-miR-200 axis works in concert with the miR-193~96~182 cluster to convergently target Foxf2 and regulate EMT, invasion and metastasis in lung cancer. In a Zeb1-independent manner, Foxf2 represses E-Cadherin and inhibits miR-200 to form a reinforcing negative feedback loop running in parallel with Zeb1 and miR-200, to regulate invasion and metastasis (Fig. 5J ).
Discussion
The molecular underpinnings driving lung cancer metastasis are largely unknown. There is a large body of evidence both in primary human tumors 27 34 , 35 , 45 , 54 , 55 . Our data elucidate a novel mechanism where Foxf2 transcriptionally represses E-Cadherin and miR-200, independent of Zeb1 to repress epithelial phenotype. We also identified a novel double-negative feedback loop between Foxf2 and miR-200, thus revealing a parallel axis to the Zeb1-miR-200 loop that controls EMT and metastasis. ECadherin and miR-200 loss are nodal events in the onset and progression of EMT and metastasis and independent control in modulating these genes implies a pivotal role for Foxf2 as a parallel regulator of EMT and metastasis. In our miRNA expression profiles on the NSCLC lines we also identified miR-205 and miR-203 which exhibited robust correlation with miR-200 and EMT and further investigation of the functional targets of these miRNAs might reveal new interesting leads in to the regulation of metastasis in lung cancers.
Materials and methods
Plasmids and reagents
Mouse or human Foxf2 cDNA was amplified by RT-PCR as a MfeI/EcoRI -MluI fragment (primers P1-P4, Suppl. Table 4 ) and cloned in the dox inducible pTRIPZ-GFP vector where the miR-30~RFP cassette was replaced with the GFP cDNA. Mouse Foxf2 shRNA (pGIPZFoxf2-shE) construct was purchased from Open-Biosystems/GE-Dharmacon (Cat#RMM4431-200375685/CloneID#V3LMM_518867). Human FOXF2 shRNA (pLKO-FOXF2-sh5) construct was cloned in pLKO vector (Addgene, Cambridge, MA) by ligating annealed oligos (P13, P14, Suppl. Table 4 ). Reporter construct for Foxf2-3′UTR was generated by RT-PCR amplification of 0.7 KB 3′ UTR region of Foxf2 mRNA, using specific primers (P5, P6, Suppl. Table 4 ) and cloned in pGL3-Promoter vector (Promega, Madison, WI). miR-200 and miR-96/182 binding site mutants of the Foxf2-3′UTR reporter construct were generated using specific primers (P7-P10, Suppl. Table 4 ) and Quick change Lightning site directed mutagenesis kit (Agilent, Santa Clara, CA). Reporter construct for ECadherin promoter was generated by PCR amplification of 1.6KB promoter region of mouse E-Cadherin using specific primers (P11, P12, Suppl. Table 4 ) and cloned in pGL3-Basic vector. shRNA construct for Zeb1 (RMM3981-201796052/CloneID#TRCN0000070818) and Scramble control vectors were purchased from Thermo-Scientific. siRNA for Zeb1 (SMARTpool:ON-TARGETplus) was purchased from Dharmacon/GE-Healthcare (Lafayette, CO).
Cell culture and transfections
All cell lines were maintained in RPMI-1640 supplemented with 10% fetal bovine serum. DNA transfections were performed with Lipofectamine-2000 or Lipofectamine-LTX reagents (Life technologies, Grand Island, NY). miRNA precursors and inhibitors (Suppl. Table 7 ) were transfected at 50nM or 100nM final concentration for 96 hours using Lipofectamin-2000 or Lipofectamine RNAi Max (Invitrogen-Life technologies) and siRNAs were transfected at 25nM final concentration using DharmaFECT-I (Dharmacon/GEHealthcare) reagents as per manufacturer's protocols.
Reporter assays
For 3′UTR reporter assays cells were co-transfected with 500 ng of the reporter construct and 50nM miRNA precursors for 24 hours and then assayed for luciferase activity after 24 hours of Doxycycline induction. For promoter-reporter assays cells were first pre-transfected for 72 hours with siRNA followed by transfection for 24 hours with 500ng of the reporter constructs, then assayed for luciferase activity after 24 hours of doxycycline induction. All reporter assays were performed using the Dual-Luciferase reporter assay system (Promega, Madison, WI).
qPCR and Western blot analysis
Total RNA was isolated and RT-PCR was performed using specific primers (Suppl. Table 4) and SYBR® Green PCR Master Mix (Life technologies). SYBR green qPCR analyses were normalized to expression of L32 (60S ribosomal gene). Taq-man assays (Life technologies; Suppl. Table 5 ) for miRNA qPCR analyses were normalized to miR-16. Western blots were performed with antibodies as listed (Suppl. Table 5 ).
Analysis of miRNA expression and EMT using TCGA pan-cancer data Level 3 TCGA pan-cancer data was used including gene expression (RNAseq) and microRNA expression (RNAseq) 3 , 28 . A summary of the samples with matched gene expression and miRNA data was provided in Supplementary Table 6 . EMT score was calculated from gene expression data using the EMT signature previously published 12 .
Pearson correlation (r value) was used to quantify the association between miRNA and EMT score.
Analysis of miRNA expression with EMT using human NSCLC cell lines
Affymetrix microRNA 4.0 samples were processed by Affymetrix Expression Console. Same cell line expression levels were averaged for each probe-set. EMT score was calculated from expression data profiled on Illumina WG v3 (GSE32036). There were 55 cell lines with both miRNA expression and EMT score. Two sample t-tests were used to test the difference between Epithelial-like and Mesenchymal-like groups (E is defined as EMT score less than 0 and M otherwise). miRNAs selected at FDR level of 0.05 were used for heatmap.
Analysis of mRNA expression array from Zeb1-transfected cells
Samples were shipped to Asuragen (Austin, TX) for processing and analysis on Affymetrix Mouse Expression Array 430A 2.0 chips as previously described 23 . Array data have been deposited into the Gene Expression Omnibus (GSE61395).
Migration and Invasion Assays
Trans-well migration (8 μM inserts; BD-Biosciences) and invasion (BD-Biosciences; #354480) assays were performed for 6 hours (human cells) and 16 hours (mouse cells) using standard protocol 23 . Inserts were stained with crystal violet and migrated or invaded cells were analyzed and counted using Image-J software.
ChIP assays
ChIP was performed as described earlier 2 , 73 with the modification that cells were fixed first with 5mM DTBP (Pierce-Thermo scientific) and then with 1% formaldehyde. Immuno precipitation was performed using anti-GFP antibody (Abcam ab290) or mock IgG (Santacruz). Promoter segment enrichment was analyzed by qPCR using primers P49-56 (Suppl. Table 4 ).
3D culture assay
Cells were seeded in a matrix comprising of matrigel (BD-Biosciences; #354230) or a mixture of matrigel and collagen (BD-Biosciences; #354236) and incubated for 6 days with regular replenishment with complete media containing 2% matrigel until formation of spheroids 23 . Spheroids were imaged and analyzed using an inverted microscope.
In vivo tumor and metastasis experiments
All animal experiments were reviewed and approved by the Institutional Animal Care and Use Committee at The University of Texas M.D. Anderson Cancer Center. Cells were sub cutaneously injected in the flanks of syngeneic 129/Sv mice of 8-10 weeks age and observed for tumor growth for a period of 4-8 weeks. Upon euthanasia, metastatic nodules on the surface of lung lobes were counted. Lung tissue was fixed in 10% Formalin and then processed for sectioning followed by haematoxylin and eosin staining.
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